Clinical Trial

A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

Study acronym: B06
Completed Phase 1
View on ClinicalTrials.gov →
Summary
This was a Phase 1, single-center, randomized, controlled, Latin-square, open-label study to evaluate the effect of ADV7103 on the gastric pH, after administering a single oral dose of ADV7103 in healthy adult participants under fasting and fed conditions
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-26.
Trial Details
NCT Number NCT07446881
Lead Sponsor Advicenne Pharma
Conditions EFFECT OF ADV7103 ON GASTRIC PH, Distal Renal Tublular Acidosis
Enrollment 12 participants
Start Date 2025-02-25
Primary Completion 2025-03-15 (estimated)
Study Completion 2025-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-10